About this trial
To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with an eating disorder diagnosis that includes purging history
Ages 18-65
Purging history =>5 years
Purging or rumination at a minimum of once daily upon admission.
Disqualifiers
Any eating disorder diagnosis that does not include purging behaviors
Ages under 18 and over 65
Patients who otherwise meet the current ACG screening guidelines (chronic GERD and 3 or more risk factors for Barrett's mentioned in the Background)
Received mandated care at time of enrollment
Trial population
ACUTE patients with a confirmed dx of AN-BP, with a purging history of \>5 year, with a frequency of purging of at least once a day.
Trial design
Cohort
Prospective
Treatments tested in this trial
EsoGuard
Devicedevice used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.
Treatment groups
Trial outcomes
Primary outcomes
Number of patients positive for BE
Individuals with severe forms of eating disorders with purging and ruminating behaviors not meeting a current screening guidelines for BE will test positive for BE
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Denver Health and Hospital Authority
Lead sponsor
Lucid Diagnostics, Inc.
Collaborator